This funding opportunity supports exploratory and developmental clinical research projects investigating the neurobiological mechanisms underlying substance use disorders. It uses the R61/R33 phased innovation award mechanism, allowing clinical trials optionally. Applicants must comply with NIH policies on foreign collaborations and subawards. Eligible applicants include a broad range of government, academic, nonprofit, and for-profit organizations, including foreign entities under specific conditions.
Eligible applicants include state, county, city, and special district governments; public and private higher education institutions; Native American tribal governments and organizations; nonprofits; for-profit organizations including small businesses; and foreign organizations under specific conditi
